top
Search terms
Results 1 - 8 of 8 - ordered by :
Ehjournal

Abstract Aims The aim of this study was to evaluate the effects of apixaban, a novel oral factor Xa inhibitor, on the need for cardiovascular hospitalization. Methods and results Our analysis is ...

European Heart Journal, Hohnloser, Stefan H., Shestakovska, Olga, Eikelboom, John, Franzosi, Maria Grazia, Tan, Ru San, Zhu, Jun, Yusuf, Salim, Connolly, Stuart J.

Date : 14/09/2013 Item size : 209869 bytes
Ehjournal

In the second of a two-part review, we discuss the use of NOAC for stroke prevention in the following subgroups of patients with AF: (vii) secondary stroke prevention in patients after stroke or ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017 Item size : 483367 bytes
Ehjournal

Methods and results Patients with AF and more than one risk factor for stroke were randomized to one of three blinded doses of betrixaban (40, 60, or 80 mg once daily) or unblinded warfarin, adjusted ...

European Heart Journal, Connolly, Stuart J., Eikelboom, John, Dorian, Paul, Hohnloser, Stefan H., Gretler, Daniel D., Sinha, Uma, Ezekowitz, Michael D.

Date : 21/05/2013
Ehjournal

In the second of a two-part review, we discuss the use of NOAC for stroke prevention in the following subgroups of patients with AF: (vii) secondary stroke prevention in patients after stroke or ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017 Item size : 490669 bytes
Ehjournal

In the second of a two-part review, we discuss the use of NOAC for stroke prevention in the following subgroups of patients with AF: (vii) secondary stroke prevention in patients after stroke or ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017 Item size : 514203 bytes
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017 Item size : 526847 bytes